Explore
0
0
Following
0
0
Notifications
0
0
Messages
0
0
History
0
0
Favorites
0
0
Rewards
0
0
About
Contact Us
Agreement
Privacy
©
2023 32Plus CO.,LTD.
History
Clear
Try to search for users or keywords
View results for "
"
Register
Sign In
CASI-Pharmaceuticals-凯信远达
PT
Lv
2
2023-5-12 14:25
· contributed a column
From China
Follow
Column
CASI制药合作伙伴BIOINVENT于 ASH 2021公布BI-1206最新临床研究成果
CASI战略合作伙伴BioInvent公布,BI-1206(抗FcγRIIB抗体)联合利妥昔单抗(抗CD20单克隆抗体)治疗复发或难治性惰性B细胞非霍奇金淋巴瘤患者(iNHL)的1/2a期临床试验中期分析获得积极成果。
1,377
4
Repost
4
91
Please
Sign In
to post a comment~
Loading...
CASI-Pharmaceuticals-凯信远达
CASI Pharmaceuticals, Inc. is a NASDAQ-listed biopharmaceutical company.
Followers
28
Feed
10
View Zone